Eris Biotech
PrivateLast Round
Accelerator
Feb 1, 2024
Total Funding Raised
$500,000
Company Overview
Eris Biotech is a biotechnology company developing small-molecule cancer therapeutics that inhibit immune suppression to re-engage the patient's immune system against solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eris Biotech Comparables
Compare Eris Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Keyhole Therapeutics | 91% | |
| Peel Therapeutics | 70% | |
| Vivace Therapeutics | 69% | |
Eris Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 1, 2024 |
Eris Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Orange Collective | Accelerator |
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2024
$500K round led by Y Combinator
Eris Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eris Biotech's valuation, stock price, and market status.